.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

PROPYLTHIOURACIL Drug Profile

« Back to Dashboard

Which patents cover Propylthiouracil, and what substitute generic drugs are available?

Propylthiouracil is a drug marketed by Watson Labs, Lilly, Ani Pharms Inc, Halsey, Lannett, Tablicaps, Perrigo, Hikma Intl Pharms, Impax Labs, Actavis Elizabeth, Abbott, Sun Pharm Inds, Anabolic, and Dava Pharms Inc. and is included in fifteen NDAs.

The generic ingredient in PROPYLTHIOURACIL is propylthiouracil. There are four drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the propylthiouracil profile page.

Summary for Tradename: PROPYLTHIOURACIL

Patents:0
Applicants:14
NDAs:15
Suppliers / Packagers: see list8
Bulk Api Vendors: see list99
Clinical Trials: see list3
Patent Applications: see list2,367
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PROPYLTHIOURACIL at DailyMed

Pharmacology for Tradename: PROPYLTHIOURACIL

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
PROPYLTHIOURACIL
propylthiouracil
TABLET;ORAL085201-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Tablicaps
PROPYLTHIOURACIL
propylthiouracil
TABLET;ORAL080840-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Halsey
PROPYLTHIOURACIL
propylthiouracil
TABLET;ORAL080015-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Abbott
PROPYLTHIOURACIL
propylthiouracil
TABLET;ORAL084075-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Perrigo
PROPYLTHIOURACIL
propylthiouracil
TABLET;ORAL084543-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc